Robert Azelby - 03 Jun 2025 Form 4 Insider Report for ADC Therapeutics SA (ADCT)

Role
Director
Signature
/s/ Lisa Kallebo, as Attorney-in-Fact for Robert Azelby
Issuer symbol
ADCT
Transactions as of
03 Jun 2025
Net transactions value
$0
Form type
4
Filing time
05 Jun 2025, 17:10:51 UTC
Previous filing
24 Feb 2025
Next filing
17 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Azelby Robert Director 430 MOUNTAIN AVENUE, SUITE 404, NEW PROVIDENCE /s/ Lisa Kallebo, as Attorney-in-Fact for Robert Azelby 05 Jun 2025 0001656998

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADCT Common Shares Award $0 +40,000 +75% $0.000000 93,005 03 Jun 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the annual grant of restricted stock units ("RSUs") made under the Issuer's 2019 Equity Incentive Plan for service as a Director. The RSUs vest one year from the grant date, subject to the Reporting Person's continued service to the Issuer. Each RSU represents a contingent right to receive one share of the Issuer's common stock.